Intrauterine programming of physiological systems: causes and consequences

Abigail L Fowden1, Dino A Giussani, Alison J Forhead

  • 1Department of Physiology, University of Cambridge, Cambridge, UK. alf1000@cam.ac.uk

Insights

Fetal development conditions impact adult physiology. Intrauterine insults, like nutrient or oxygen changes, permanently alter gene and tissue development, leading to later-life diseases.

Area of Science:

  • Developmental biology
  • Physiology
  • Endocrinology

Background:

  • Intrauterine conditions significantly influence mammalian fetal development.
  • Nutrient, oxygen, and hormonal availability in utero programs later physiological function.
  • Developmental insults can lead to adult cardiovascular and metabolic dysfunction.

Purpose of the Study:

  • To explore the long-term effects of intrauterine programming on mammalian physiology.
  • To understand how developmental insults impact gene, cell, tissue, organ, and system development.
  • To identify the mechanisms linking intrauterine environment to adult disease.

Main Methods:

  • Review of existing literature on developmental origins of health and disease.
  • Analysis of studies investigating the impact of specific intrauterine insults.
  • Examination of molecular and structural changes at various developmental levels.

Main Results:

  • Intrauterine programming causes permanent structural and functional changes.
  • The specific outcome depends on the timing, duration, severity, and type of developmental insult.
  • Programmed changes can lead to overt disease, especially with aging.

Conclusions:

  • The intrauterine environment is a critical determinant of lifelong physiological health.
  • Early-life insults can establish a predisposition to adult-onset diseases.
  • Understanding intrauterine programming is key to preventing age-related diseases.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...